324 related articles for article (PubMed ID: 31219199)
1. Upregulation of miR-675-5p induced by lncRNA H19 was associated with tumor progression and development by targeting tumor suppressor p53 in non-small cell lung cancer.
Zheng ZH; Wu DM; Fan SH; Zhang ZF; Chen GQ; Lu J
J Cell Biochem; 2019 Nov; 120(11):18724-18735. PubMed ID: 31219199
[TBL] [Abstract][Full Text] [Related]
2. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
3. High expression of lncRNA MEG3 participates in non-small cell lung cancer by regulating microRNA-7-5p.
Wu JL; Meng FM; Li HJ
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5938-5945. PubMed ID: 30280775
[TBL] [Abstract][Full Text] [Related]
4. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
[TBL] [Abstract][Full Text] [Related]
5. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
Liu L; Chen Y; Li Q; Duan P
J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
[TBL] [Abstract][Full Text] [Related]
6. Association of long non-coding RNA H19 and microRNA-21 expression with the biological features and prognosis of non-small cell lung cancer.
Zhou Y; Sheng B; Xia Q; Guan X; Zhang Y
Cancer Gene Ther; 2017 Aug; 24(8):317-324. PubMed ID: 28799568
[TBL] [Abstract][Full Text] [Related]
7. p53/miR-30a-5p/ SOX4 feedback loop mediates cellular proliferation, apoptosis, and migration of non-small-cell lung cancer.
Quan X; Li X; Yin Z; Ren Y; Zhou B
J Cell Physiol; 2019 Dec; 234(12):22884-22895. PubMed ID: 31124131
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-122-5p promotes the development of non-small cell lung cancer via downregulating p53 and activating PI3K-AKT pathway.
Fan X; Wu X
J BUON; 2019; 24(1):273-279. PubMed ID: 30941980
[TBL] [Abstract][Full Text] [Related]
10. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.
Tung MC; Lin PL; Cheng YW; Wu DW; Yeh SD; Chen CY; Lee H
Oncotarget; 2016 May; 7(22):32362-74. PubMed ID: 27083050
[TBL] [Abstract][Full Text] [Related]
11. LncRNA H19 serves as a ceRNA and participates in non-small cell lung cancer development by regulating microRNA-107.
Qian B; Wang DM; Gu XS; Zhou K; Wu J; Zhang CY; He XY
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5946-5953. PubMed ID: 30280776
[TBL] [Abstract][Full Text] [Related]
12. Up-regulated circular RNA VANGL1 contributes to progression of non-small cell lung cancer through inhibition of miR-195 and activation of Bcl-2.
Wang L; Ma H; Kong W; Liu B; Zhang X
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31076544
[TBL] [Abstract][Full Text] [Related]
13. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1.
Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
Cell Physiol Biochem; 2018; 46(1):93-106. PubMed ID: 29587281
[TBL] [Abstract][Full Text] [Related]
15. LINC00324 affects non-small cell lung cancer cell proliferation and invasion through regulation of the miR-139-5p/IGF1R axis.
Zhang M; Lin B; Liu Y; Huang T; Chen M; Lian D; Deng S; Zhuang C
Mol Cell Biochem; 2020 Oct; 473(1-2):193-202. PubMed ID: 32734536
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-β1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137.
Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
Genet Test Mol Biomarkers; 2018 Jun; 22(6):333-342. PubMed ID: 29812958
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
Guo D; Wang Y; Ren K; Han X
Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of lncRNA DANCR functions as an oncogenic role in non-small lung cancer by regulating miR-214-5p/CIZ1 axis.
Chen YR; Wu YS; Wang WS; Zhang JS; Wu QG
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2539-2547. PubMed ID: 32196604
[TBL] [Abstract][Full Text] [Related]
20. LINC00657/miR-26a-5p/CKS2 ceRNA network promotes the growth of esophageal cancer cells via the MDM2/p53/Bcl2/Bax pathway.
Zhang XM; Wang J; Liu ZL; Liu H; Cheng YF; Wang T
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
